Ontology highlight
ABSTRACT: Objective
To develop and confirm an individualized predictive model to ascertain the probability of deep venous thrombosis in patients with acute poisoning after undergoing hemoperfusion.Methods
Three hundred eleven patients with acute poisoning who were admitted to a hospital in China between October 2017 and February 2019 were included in the development group. Eighty patients with acute poisoning who were admitted between February and May 2019 were included in the validation group. The independent risk factors for deep venous thrombosis were examined. An individualized predictive model was developed using regression coefficients.Results
The number of catheter indwelling days, having a catheter while being transported, elevated serum homocysteine concentrations, and dyslipidemia were independent risk factors for deep venous thrombosis following hemoperfusion in patients with acute poisoning. The areas under the receiver operating characteristic curve of the development and validation groups were 0.713 and 0.702, respectively, which suggested that the prediction model had good discrimination capacity. The calibration belts of the two groups were ideal.Conclusions
Our prediction model has a moderate predictive effect for the occurrence of deep venous thrombosis in patients with acute poisoning. In clinical practice, this model could be combined with a common thrombosis risk assessment model.
SUBMITTER: Li X
PROVIDER: S-EPMC9021492 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
Li Xiuqin X Liu Jing J Cui Siqi S Jian Tianzi T Ma Shuang S Shi Longke L Lin Ying Y Zhang Juan J Zheng Yingying Y Zhang Yanxia Y Jian Xiangdong X Luan Xiaorong X Kan Baotian B
The Journal of international medical research 20220401 4
<h4>Objective</h4>To develop and confirm an individualized predictive model to ascertain the probability of deep venous thrombosis in patients with acute poisoning after undergoing hemoperfusion.<h4>Methods</h4>Three hundred eleven patients with acute poisoning who were admitted to a hospital in China between October 2017 and February 2019 were included in the development group. Eighty patients with acute poisoning who were admitted between February and May 2019 were included in the validation g ...[more]